David Krempa
Chief Business Officer at Eton Pharmaceuticals, Inc. (ETON)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 6SEC | ETONEton Pharmaceuticals, Inc. | Sell | 4,16643,381 held (−9%) | $55.07 | $229K | +0.3% |
| Aug 24SEC | ETONEton Pharmaceuticals, Inc. | Sell | 25,00037,025 held (−40%) | $65.07 | $1.6M | -15.2% |
| May 27SEC | ETONEton Pharmaceuticals, Inc. | Sell | 32,96335,083 held (−48%) | $33.22 | $1.1M | +66.2% |
| May 27SEC | ETONEton Pharmaceuticals, Inc. | Sell | 9,31525,768 held (−27%) | $33.88 | $316K | +63.0% |
| May 27SEC | ETONEton Pharmaceuticals, Inc. | Sell | 51925,249 held (−2%) | $35.00 | $18K | +57.7% |
| May 27SEC | ETONEton Pharmaceuticals, Inc. | Sell | 37,52425,249 held (−60%) | $31.49 | $1.2M | +75.3% |
| May 27SEC | ETONEton Pharmaceuticals, Inc. | Sell | 19,67925,249 held (−44%) | $31.47 | $619K | +75.4% |
- Sell
Chief Business Officer David Krempa sold $1.6M of ETON at $65.07 — cuts the stake by 40%.
- Sell
Chief Business Officer David Krempa sold $1.1M of ETON at $33.22 — cuts the stake by 48%.
- Sell
Chief Business Officer David Krempa sold $316K of ETON at $33.88 — cuts the stake by 27%.
- Sell
Chief Business Officer David Krempa sold $1.2M of ETON at $31.49 — cuts the stake by 60%.
- Sell
Chief Business Officer David Krempa sold $619K of ETON at $31.47 — cuts the stake by 44%.